Atherosclerosis
20 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Calf Plantar flexion + Dietary nitrate for peripheral arterial disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Canakinumab for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cardiovascular Polypill (Valsartan, Atorvastatin, Aspirin) + Colchicine 0.5 mg for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cardiovascular Polypill (Valsartan, Atorvastatin, Aspirin) + Colchicine-placebo 0.5 mg for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clazakizumab for atherosclerosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Colchicine 0.5 mg for atherosclerosis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Colchicine 0.5 mg + Usual Care Group for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Colchicine-placebo 0.5 mg + Usual Care Group for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Left main stenting with intravascular lithotripsy for atherosclerosis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Lepodisiran for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Lepodisiran Sodium for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Maridebart Cafraglutide for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Muvalaplin for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Polycap for atherosclerosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Retatrutide for peripheral arterial disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Selnoflast for atherosclerosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tertinat for atherosclerosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VERVE-102 for atherosclerosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ziltivekimab for atherosclerosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |